Page 2 - Fulcrum Therapeutics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fulcrum therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fulcrum Therapeutics Inc Today - Breaking & Trending Today

HC Wainwright Equities Analysts Reduce Earnings Estimates for Fulcrum Therapeutics, Inc. (NASDAQ:FULC)

Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Free Report) – Research analysts at HC Wainwright decreased their Q2 2024 earnings per share (EPS) estimates for Fulcrum Therapeutics in a report issued on Tuesday, May 14th. HC Wainwright analyst A. Fein now forecasts that the company will post earnings of ($0.43) per share for the quarter, down from […] ....

United States , Piper Sandler , Greg Tourangeau , Securities Exchange Commission , Fulcrum Therapeutics Inc , China Universal Asset Management Co , Capstone Investment Advisors , Brown Wealth Management , Royal Bank , Sg Americas Securities , Goldman Sachs Group , Fulcrum Therapeutics , Free Report , Fulcrum Therapeutic , Get Free Report , Exchange Commission , Universal Asset Management , Investment Advisors , Wealth Management , Fulcrum Therapeutics Daily ,

Fulcrum Therapeutics (NASDAQ:FULC) Receives Buy Rating from HC Wainwright

Fulcrum Therapeutics (NASDAQ:FULC) Receives Buy Rating from HC Wainwright
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United States , Greg Tourangeau , Piper Sandler , China Universal Asset Management Co , Fulcrum Therapeutics Inc , Sg Americas Securities , Securities Exchange Commission , Royal Bank , Brown Wealth Management , Goldman Sachs Group , Capstone Investment Advisors , Fulcrum Therapeutics , Free Report , Get Free Report , Exchange Commission , Universal Asset Management , Investment Advisors , Wealth Management , Fulcrum Therapeutics Daily ,

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Sees Significant Increase in Short Interest

Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Free Report) was the target of a large increase in short interest during the month of April. As of April 30th, there was short interest totalling 3,000,000 shares, an increase of 18.6% from the April 15th total of 2,530,000 shares. Based on an average daily trading volume, of 598,700 […] ....

United States , Greg Tourangeau , Piper Sandler , Goldman Sachs Group , Mirae Asset Global Investments Co , Royal Bank , Vanguard Group Inc , Sg Americas Securities , China Universal Asset Management Co , Fulcrum Therapeutics Company Profile , Fulcrum Therapeutics Inc , Fulcrum Therapeutics , Get Free Report , Point Capital , Asset Global Investments , China Universal Asset Management , Universal Asset Management , Fulcrum Therapeutics Daily ,

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Short Interest Up 18.6% in April

Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Free Report) saw a large increase in short interest during the month of April. As of April 30th, there was short interest totalling 3,000,000 shares, an increase of 18.6% from the April 15th total of 2,530,000 shares. Based on an average daily trading volume, of 598,700 shares, the short-interest […] ....

United States , Piper Sandler , Greg Tourangeau , Sg Americas Securities , Vanguard Group Inc , China Universal Asset Management Co , Royal Bank , Fulcrum Therapeutics Inc , Fulcrum Therapeutics Company Profile , Goldman Sachs Group , Mirae Asset Global Investments Co , Securities Exchange Commission , Fulcrum Therapeutics , Get Free Report , Exchange Commission , Point Capital , Asset Global Investments , China Universal Asset Management , Universal Asset Management , Fulcrum Therapeutics Daily ,

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Short Interest Update

Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Free Report) was the recipient of a significant increase in short interest in April. As of April 30th, there was short interest totalling 3,000,000 shares, an increase of 18.6% from the April 15th total of 2,530,000 shares. Based on an average trading volume of 598,700 shares, the short-interest ratio […] ....

United States , Greg Tourangeau , Dekabank Deutsche Girozentrale , Piper Sandler , Fulcrum Therapeutics Company Profile , Fulcrum Therapeutics Inc , Royal Bank , Goldman Sachs Group , Citigroup Inc , Jump Financial , Fulcrum Therapeutics , Get Free Report , Therapeutics Trading Down , Fulcrum Therapeutics Daily ,